VJET 10-Q filed 2026-11-16 | Key takeaways
VJET filed its 10-Q; the most relevant disclosure change is expanded Going concern: Company disclosed substantial doubt about its ability to continue as a going concern within 12 months from the date of issuance due to accumulated deficit of $329.6 million, working capital deficit of $3.2 million, and cash of $2.4 million. Customer concentration: Customer One represented 14% of revenue; Customer One represented 17% of revenue.
Key takeaways
5-7 ranked factual bullets
Key metrics
Customer concentration
Disclosure changes
- Going concern
Company disclosed substantial doubt about its ability to continue as a going concern within 12 months from the date of issuance due to accumulated deficit of $329.6 million, working capital deficit of $3.2 million, and cash of $2.4 million.
Indicates significant financial distress and potential inability to fund operations without additional capital raises - Discontinued operations
In September 2026, the company classified its VIVO and LockeT medical device businesses as discontinued operations and the related Disposal Group as held for sale, recognizing a $12.5 million noncash loss on impairment of assets held for sale.
Significant strategic shift away from cardiac electrophysiology toward private aviation; large impairment charge impacts reported results - Business combination - FLYTE
Company acquired 100% of FLYTE (private aviation) on March 9, 2026 for total purchase price of $14.8 million, recognizing $12.2 million in goodwill and $4.1 million in identifiable intangible assets.
Transformative acquisition creating a new private aviation operating segment; substantial goodwill raises impairment risk - Series C and D Convertible Preferred Stock
Company issued 12,874 shares of Series C Convertible Preferred Stock and 6,809 shares of Series D Convertible Preferred Stock during the nine months ended September 30, 2026; conversion prices subsequently reduced to $1.00 per share in October 2026.
Significant dilution potential from preferred stock conversions at reduced prices - Series J Convertible Preferred Stock conversion price
Series J conversion price reduced from $15.60 to $2.30 on October 1, 2026 and further to $1.00 on October 10, 2026, with stockholders approving the board's authority to reduce the price below $2.30.
Substantial additional dilution to common stockholders from CEO's and affiliate's Series J preferred conversion - Reverse stock split
1-for-10 reverse stock split effective October 5, 2026, reducing common shares outstanding from 14.4 million to 3.4 million; NYSE American rules limiting cumulative reverse stock split ratios may restrict near-term reverse splits.
Reduces share count but also share price; potential violation of NYSE American continued listing standards
Primary source
TickerStar generated this brief from an official company, investor-relations, earnings-call, or regulatory source. Review the primary material before making an investment decision.
Open SEC filingFollow VJET in real time
Get material earnings, filing, IR, and earnings-call alerts by email.